Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Understanding oxidative stress and HTRA1 locus in abnormal angiogenesis resulting in wet AMD pathology is an important step in developing a novel therapeutic approach.
|
31100080 |
2019 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
AMD has a strong genetic association with high-temperature requirement A 1 (HTRA1).
|
30273602 |
2018 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Association between polymorphism rs11200638 in the HTRA1 gene and the response to anti-VEGF treatment of exudative AMD: a meta-analysis.
|
28637435 |
2017 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, we confirm that ARMS2, HTRA1 and CFH variants are associated with neovascular AMD in the Thai population.
|
28703135 |
2017 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Six single nucleotide polymorphisms (SNPs) in this region and two known AMD-associated SNPs in CFH (rs800292) and HTRA1 (rs11200638) were genotyped in a Han Chinese cohort composed of 490 neovascular AMD patients, 419 PCV patients and 1316 controls.
|
26861912 |
2016 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results revealed that HTRA1 rs2672598 is more significantly associated with exudative AMD than PCV in ARMS2/HTRA1 region, and it is responsible for elevated HTRA1 transcriptional activity and HTRA1 protein expression.
|
27338780 |
2016 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Synonymous variants in HTRA1 implicated in AMD susceptibility impair its capacity to regulate TGF-β signaling.
|
26310622 |
2015 |
Glycogen storage disease type II
|
0.100 |
Biomarker
|
disease |
BEFREE |
Only one locus, the ARMS2/HTRA1 was a significant genetic risk factor for Korean exudative AMD, including its subtypes, PCV and typical CNV.
|
26171855 |
2015 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CFH (rs1410996), HTRA1 (rs112000638) and ARMS2 (rs10490923) gene polymorphisms are associated with AMD risk in Spanish patients.
|
23534868 |
2014 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Significantly, interactions were identified among FPR1 rs78488639, CFH rs800292, and HTRA1 rs11200638 in both exudative AMD and PCV.
|
25277308 |
2014 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The association of SKIV2L rs429608 with neovascular AMD remained significant after adjusting for CFH rs800292 and HTRA1 rs11200638.
|
23260260 |
2013 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
HTRA1 gene polymorphism may influence patient response to treatment with intravitreal ranibizumab for neovascular AMD.
|
24080590 |
2013 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CFH, ARMS2 and HTRA1 genotypes may influence patient response to treatment with intravitreal bevacizumab for neovascular AMD.
|
22594510 |
2012 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
There is a strong and consistent association of the ARMS2/HTRA1 locus with both exudative AMD and PCV, suggesting the two disorders share, at least partially, similar molecular mechanisms.
|
22491416 |
2012 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We identified a sample of patients with neovascular AMD, that in previous studies had been shown to be at elevated risk for the disease through environmental factors such as cigarette smoking and genetic variants including the complement factor H gene (CFH) on chromosome 1q25 and variants in the ARMS2/HtrA serine peptidase 1 (HTRA1) gene(s) on chromosome 10q26.
|
21682878 |
2011 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
AMD donors carrying the ARMS2 and HTRA1 risk alleles were the most likely to exhibit elevated CEP markers.
|
20238042 |
2010 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26.
|
19933195 |
2010 |
Glycogen storage disease type II
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study demonstrated the significant association of the 10q26 SNPs (HTRA1 and LOC387715) in an AMD cohort from Korea and was consistent with previous studies from other populations.
|
20456446 |
2010 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
To investigate the effect of single nucleotide polymorphisms (SNPs) and haplotypes in the genes encoding age-related maculopathy susceptibility 2 (LOC387715/ARMS2) and high-temperature requirement A-1 (HTRA1) in a case-control study in a Chinese cohort of individuals with exudative age-related macular degeneration (AMD).
|
19491722 |
2009 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
AMD donors carrying the ARMS2 and HTRA1 risk alleles were the most likely to exhibit elevated CEP markers.
|
19202148 |
2009 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The coding HTRA1 SNP rs2293870, not part of the significant haplotypes containing rs10490924 and rs11200638, showed as strong an association with increased susceptibility to neovascular AMD.
|
18164066 |
2008 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Other than variants on 1q32-q22, only two SNPs, rs9288410 (MAP2) on 2q34-q35 and rs2014307 (PLEKHA1/HTRA1) on 10q26 were significantly associated with AMD status (P = .03 and P < 10-6 respectively).
|
18541031 |
2008 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
There was no significant difference in the incidence of CFH Y402H (P = 0.598) and HTRA1 rs11200638 (P = 0.290) between eyes with typical exudative AMD and with PCV.
|
18939352 |
2008 |
Glycogen storage disease type II
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The ORs of exudative AMD for individuals carrying one copy risk allele and two copy risk alleles were 2.57 (1.21 - 5.45) and 4.76 (2.15 - 10.55) respectively, with correspondent PARs of 28.3% (2.0% - 40.5%) and 38.2% (21.8% - 45.4%). rs11200638 in HTRA1 was another susceptible locus for AMD and the risk homozygotes were significantly susceptible for exudutive AMD (OR = 3.98, 1.88 - 8.43) with PAR of 38.9% (24.3% - 45.8%).
|
19187590 |
2008 |
Glycogen storage disease type II
|
0.100 |
Biomarker
|
disease |
BEFREE |
This finding is consistent with the role of HTRA1 in AMD pathogenesis and will help aid in the clinical management and prognosis of AMD patients.
|
18206206 |
2008 |